🚀 Our new Pitch Deck Review is live on Product Hunt today!
Support us on Product Hunt

BSI SA

Total investments

5

Average round size

38M

Portfolio companies

4

Rounds per year

0.03

Follow on index

0.20

Exits

2

Stages of investment
Late Stage Venture
Areas of investment
BiotechnologyHealth CareGeneticsMedical DeviceMedicalPharmaceuticalTherapeuticsBiopharma

Summary

BSI SA is the famous Corporate Investor, which was founded in 1873. The fund was located in Europe if to be more exact in Switzerland. The main office of represented Corporate Investor is situated in the Lugano.

Opposing the other organizations, this BSI SA works on 11 percentage points more the average amount of lead investments. The important activity for fund was in 2010. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The top amount of exits for fund were in 2016.

Among the most popular fund investment industries, there are Pharmaceutical, Health Care. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Perlegen Sciences, VisionCare Ophthalmic Technologies, GlobeImmune.

The typical case for the fund is to invest in rounds with 4 participants. Despite the BSI SA, startups are often financed by Three Arch Partners, Pitango Venture Capital, ONSET Ventures. The meaningful sponsors for the fund in investment in the same round are Three Arch Partners, Saints Capital, ProQuest Investments. In the next rounds fund is usually obtained by ProQuest Investments, Aravis Ventures, SternAegis Ventures.

Show more

Investments analytics

Analytics

Total investments
5
Lead investments
0
Exits
2
Rounds per year
0.03
Follow on index
0.20
Investments by industry
  • Biotechnology (4)
  • Health Care (4)
  • Pharmaceutical (2)
  • Genetics (2)
  • Medical (2)
  • Show 3 more
Investments by region
  • United States (4)
  • Switzerland (1)
Peak activity year
2010

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
21
Group Appearance index
1.00
Avg. company exit year
8

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company nameDeal dateIndustryDeal stageDeal sizeLocation
Telormedix30 Sep 2008Biotechnology, Health Care, Therapeutics, BiopharmaEarly Stage Venture19MSwitzerland, Ticino

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.